CLINICAL_TRIALS
trial_result
· 2016-08-03
Clinical Trial Update: Optimum Immunosuppression in Renal Transplant Recipients.New Onset Diabetes After Transplantation [Phase 4]
Summary
A Phase 4 study on immunosuppression strategies in renal transplant recipients. The study focused on new-onset diabetes after transplantation and was terminated…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Armando Torres Ramírez | Conditions: Diabetes Mellitus, Adult-Onset | Phase 4 | Status: TERMINATED | Results posted: 2016-08-03